Spörl E, Raiskup-Wolf F, Pillunat L E
Augenklinik, Universitätsklinikum Dresden, Dresden.
Klin Monbl Augenheilkd. 2008 Feb;225(2):131-7. doi: 10.1055/s-2008-1027221.
The reduced mechanical stability of the cornea in keratoconus or in keratectasia after Lasik may be increased by photooxidative cross-linking of corneal collagen. The biophysical principles are compiled for the safe and effective application of this new treatment method.
The setting of the therapy parameters should be elucidated from the absorption behaviour of the cornea. The safety of the method for the endothelium cells and the lens will be discussed. The induced cross-links are shown to be the result of changes in the physico-chemical properties of the cornea.
To reach a high absorption of the irradiation energy in the cornea, riboflavin of a concentration of 0.1% and UV light of a wavelength of 370 nm, corresponding to the relative maximum of absorption of riboflavin, were used. An irradiance of 3 mW/cm(2) and an irradiation time of 30 min lead to an increase of the mechanical stiffness. The endothelium cells will be protected due to the high absorption within the cornea, that means the damaging threshold of the endothelium cells will not be reached in a 400 microm thick stroma. As evidence for cross-links we can consider the increase of the biomechanical stiffness, the increased resistance against enzymatic degradation, a higher shrinkage temperature, a lower swelling rate and an increased diameter of collagen fibres.
The therapy parameters were tested experimentally and have been proven clinically in the corneal collagen cross-linking. These parameters should be respected to reach a safe cross-linking effect without damage of the adjacent tissues.
圆锥角膜或准分子激光原位角膜磨镶术(Lasik)后角膜扩张时角膜机械稳定性降低,可通过角膜胶原的光氧化交联作用增强。本文阐述了这种新治疗方法安全有效应用的生物物理原理。
应根据角膜的吸收特性确定治疗参数。讨论该方法对内皮细胞和晶状体的安全性。诱导交联显示为角膜物理化学性质变化的结果。
为使角膜对辐射能量有高吸收,使用了浓度为0.1%的核黄素和波长为370nm的紫外线,该波长对应核黄素吸收的相对最大值。3mW/cm²的辐照度和30分钟的照射时间可使机械硬度增加。由于角膜内的高吸收可保护内皮细胞,这意味着在400微米厚的基质中不会达到内皮细胞的损伤阈值。作为交联的证据,我们可以考虑生物力学硬度的增加、对酶降解抵抗力的增加、更高的收缩温度、更低的肿胀率以及胶原纤维直径的增加。
治疗参数已通过实验测试,并在角膜胶原交联中得到临床验证。应遵循这些参数以实现安全的交联效果而不损伤相邻组织。